CUAMC
MDGL icon

China Universal Asset Management Company’s Madrigal Pharmaceuticals MDGL Stock Holding History

China Universal Asset Management Company’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
3,669
-602
-14% -$308K 0.12% 134
2026
Q1 		$2.24M Buy
4,271
+570
+15% +$272K 0.17% 102
2025
Q4 		$2.16M Sell
3,701
-206
-5% -$105K 0.17% 102
2025
Q3 		$1.79M Sell
3,907
-552
-12% -$206K 0.15% 123
2025
Q2 		$1.35M Buy
4,459
+30
+0.7% +$8.94K 0.13% 139
2025
Q1 		$1.47M Sell
4,429
-196
-4% -$64.4K 0.14% 139
2024
Q4 		$1.43M Buy
4,625
+449
+11% +$126K 0.13% 122
2024
Q3 		$886K Buy
4,176
+1,672
+67% +$428K 0.1% 149
2024
Q2 		$702K Sell
2,504
-1,297
-34% -$309K 0.1% 127
2024
Q1 		$1.02M Buy
3,801
+1,509
+66% +$356K 0.13% 129
2023
Q4 		$530K Buy
2,292
+1,824
+390% +$319K 0.1% 143
2023
Q3 		$68.3K Buy
468
+228
+95% +$42.9K 0.02% 219
2023
Q2 		$55.4K Sell
240
-6
-2% -$1.63K 0.02% 185
2023
Q1 		$59.6K Buy
246
+72
+41% +$19.6K 0.02% 147
2022
Q4 		$50.5K Sell
174
-2,424
-93% -$237K 0.02% 138
2022
Q3 		$169K Buy
+2,598
New +$181K 0.07% 97

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

China Universal Asset Management Company's MDGL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Madrigal Pharmaceuticals (MDGL) stake by 14% in Q2 2026, selling an estimated $308K and leaving 3,669 shares worth $1.97M. The position accounts for 0.12% of the portfolio, ranked #134.

China Universal Asset Management Company first reported a position in MDGL in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.24M in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • China Universal Asset Management Company held 3,669 shares of Madrigal Pharmaceuticals worth $1.97M as of Q2 2026.
  • China Universal Asset Management Company sold 602 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $308K.
  • Madrigal Pharmaceuticals made up 0.12% of China Universal Asset Management Company's portfolio in Q2 2026, its #134 holding.
  • China Universal Asset Management Company first reported a position in Madrigal Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Madrigal Pharmaceuticals position peaked at $2.24M in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.